Abstract:A number of multiresistant pathogens including Acinetobacter baumannii (A. baumannii) place a heavy burden on ventilator-associated pneumonia (VAP) patients in intensive care units (ICU). It is critically important to differentiate between bacterial infection and colonization to avoid prescribing unnecessary antibiotics. Quantitative culture of lower respiratory tract (LRT) specimens, however, requires invasive procedures. Nowadays, volatile organic compounds (VOCs) have been studied in vitro and in vivo to identify pathogen-derived biomarkers. Therefore, an exploratory pilot study was conceived for a proof of concept that the appearance and level of A. baumannii-derived metabolites might be correlated with the presence of the pathogen and its ecological niche (i.e. the infection and colonization states) in ICU ventilated patients. Twenty patients with A. baumannii VAP (infection group), 20 ventilated patients with LRT A. baumannii colonization (colonization group) and 20 ventilated patients with neurological disorders, but without pneumonia or A. baumannii colonization (control group) were enrolled in the in vivo pilot study. A clinical isolate of A. baumannii strains was used for the in vitro culture experiment. The adsorptive preconcentration (solid-phase microextraction fiber and Tenax(®) TA) and analysis technique of gas chromatography-mass spectrometry were applied in the studies. Breath profiles could be visually differentiated between A. baumannii cultivation in vitro and culture medium, and among in vivo groups. In the in vitro experiment, nine compounds of interest (2,5-dimethyl-pyrazine, 1-undecene, isopentyl 3-methylbutanoate, decanal, 1,3-naphthalenediol, longifolene, tetradecane, iminodibenzyl and 3-methyl-indene) in the headspace were found to be possible A. baumannii derivations. While there were eight target VOCs (1-undecene, nonanal, decanal, 2,6,10-trimethyl-dodecane, 5-methyl-5-propyl-nonane, longifolene, tetradecane and 2-butyl-1-octanol) exhibiting characteristics of A. baumannii VAP derivations. The selected VOC profile in vivo could be adopted to efficiently differentiate the presence of LRT A. baumannii from its absence, and LRT A. baumannii infection from its colonization (AUC = 0.89 and 0.88, respectively). It is not feasible to simply transfer the metabolic biomarkers from the in vitro condition to in vivo. The direct detection of exhaled A. baumannii-derived VOCs may be adopted for an early alert of the LRT bacterial presence in ventilated ICU patients, and even in different parasitic states of A. baumannii (i.e. infection and colonization). However, further refinement and validation are required before its clinical use.

24.5 A 0.5V 1.27mw Nose-on-a-chip for Rapid Diagnosis of Ventilator-Associated Pneumonia.

A fully integrated nose-on-a-chip for rapid diagnosis of ventilator-associated pneumonia

Breath Analysis for Noninvasively Differentiating Acinetobacter Baumannii Ventilator-Associated Pneumonia from Its Respiratory Tract Colonization of Ventilated Patients

The Love Wave Biosensor for the Detection of the Bacterial Pneumonia Biomarker C-reactive Protein

Machine Learning Methods Applied to Predict Ventilator-Associated Pneumonia with Infection via Sensor Array of Electronic Nose in Intensive Care Unit.

Rapid Identification of Pathogens Associated with Ventilator-Associated Pneumonia by Nanopore Sequencing

Rational Lung Tissue and Animal Models for Rapid Breath Tests to Determine Pneumonia and Pathogens

Rapid Screen for Ventilator Associated Pneumonia Using Exhaled Volatile Organic Compounds

Internet of Things Assisted Wireless Body Area Network Enabled Biosensor Framework for Detecting Ventilator and Hospital-Acquired Pneumonia

Molecular Quantification of Pseudomonas Aeruginosa from Respiratory Samples in Patients with Suspected Ventilator Associated Pneumonia

Wireless, battery-free, multifunctional integrated bioelectronics for respiratory pathogens monitoring and severity evaluation

Early Detection of Ventilator-Associated Pneumonia from Exhaled Breath in ICU Patients

Early Detection of Ventilator-associated Pneumonia From Exhaled Breath in Intensive Care Unit Patients

A rapid, low-cost, and microfluidic chip-based system for parallel identification of multiple pathogens related to clinical pneumonia

Clinical evaluation of a rapid 13-pathogen detecting loop-mediated isothermal amplification chip in ventilator-associated pneumonia patients

Novel fast pathogen diagnosis method for severe pneumonia patients in the intensive care unit: randomized clinical trial

PCR Coupled to Electrospray Ionization Mass Spectrometry for Microbiological Diagnosis and Surveillance of Ventilator-Associated Pneumonia.

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification

Rapid, accurate, and novel diagnostic technique for respiratory pathogens: Clinical application of loop-mediated isothermal amplification assay in older patients with pneumonia, a multicenter prospective observational study

Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unit.

Development of a self-contained microfluidic chip and an internet-of-things-based point-of-care device for automated identification of respiratory viruses